Fill out the form to download the PDF file. This case study highlights the benefits of the Inscopix platform for preclinical migraine screening using a novel blood vessel imaging approach, with data showing response to migraine-inducer compounds with and without treatment that reveal enhanced mechanistic differences for novel therapeutics using the Inscopix platform.